David Lalloo

Q: What Schools Are Affiliated With David Lalloo

David Lalloo is affiliated with the following schools: University of Liverpool, University of Oxford, Liverpool School of Tropical Medicine

David Lalloo's AcademicInfluence.com Rankings

David Lalloo

Philosophy

#9988

World Rank

#13639

Historical Rank

Logic

#6926

World Rank

#8495

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David Lalloo's Degrees

Masters Medicine University of Liverpool
PhD Tropical Medicine University of Liverpool

Why Is David Lalloo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Griffith Lalloo is a British parasitologist, and the director of the Liverpool School of Tropical Medicine since January 2019, and Professor of Tropical Medicine there. Lalloo trained as a doctor in Newcastle upon Tyne.

(See a Problem?)

David Lalloo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths (2008) (1490)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (1083)
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries (2020) (592)
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants (1994) (443)
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults (2002) (424)
Snake Envenoming: A Disease of Poverty (2009) (422)
Combination antifungal therapy for cryptococcal meningitis. (2013) (367)
Antigenic oscillations and shifting immunodominance in HIV-1 infections (1995) (357)
UK malaria treatment guidelines. (2007) (302)
Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. (2004) (291)
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. (2007) (270)
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa (2018) (252)
Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation (1997) (217)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (201)
Artesunate versus quinine for treating severe malaria. (2011) (188)
Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. (1996) (174)
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. (2016) (166)
Evaluation of Six Commercial Point-of-Care Tests for Diagnosis of Acute Dengue Infections: the Need for Combining NS1 Antigen and IgM/IgG Antibody Detection To Achieve Acceptable Levels of Accuracy (2011) (166)
Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. (2014) (165)
Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: Determinants operating at environmental and institutional level. (2004) (160)
Neurotoxicity in Snakebite—The Limits of Our Knowledge (2013) (152)
Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial (2011) (141)
Antimalarial pharmacology and therapeutics of atovaquone (2013) (139)
UK malaria treatment guidelines 2016 (2016) (128)
Comparison of Seven Commercial Antigen and Antibody Enzyme-Linked Immunosorbent Assays for Detection of Acute Dengue Infection (2012) (126)
Oral cholera vaccines: use in clinical practice. (2006) (123)
Transactional sex and HIV: understanding the gendered structural drivers of HIV in fishing communities in Southern Malawi (2012) (121)
A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. (2001) (118)
A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease (2010) (113)
Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms (2004) (104)
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. (2012) (103)
Mapping the Risk of Snakebite in Sri Lanka - A National Survey with Geospatial Analysis (2016) (102)
A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. (2002) (99)
Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population (2013) (98)
Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co‐infection in northwest Ethiopia (2010) (94)
Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi (2016) (88)
Delayed Psychological Morbidity Associated with Snakebite Envenoming (2011) (86)
Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. (1995) (83)
Malaria in adolescence: burden of disease, consequences, and opportunities for intervention. (2006) (80)
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (2022) (80)
Combination antifungal therapy for cryptococcal meningitis. (2013) (79)
Artesunate versus quinine for treating severe malaria. (2012) (78)
Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi (2012) (73)
A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi (2013) (72)
Estimates of disease burden due to land-snake bite in Sri Lankan hospitals. (2005) (72)
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi (2009) (68)
Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings (2017) (67)
Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. (1995) (67)
Underestimation of snakebite mortality by hospital statistics in the Monaragala District of Sri Lanka. (2006) (65)
Malaria after international travel: a GeoSentinel analysis, 2003–2016 (2017) (64)
Schistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails (2014) (61)
Poor Diagnostic Accuracy of Commercial Antibody-Based Assays for the Diagnosis of Acute Chikungunya Infection (2011) (60)
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2 (2022) (60)
The epidemiology of snake bite in Central Province and National Capital District, Papua New Guinea. (1995) (60)
Severe and complicated falciparum malaria in Melanesian adults in Papua New Guinea. (1996) (60)
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. (2011) (60)
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. (2011) (59)
A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi (2014) (58)
Seasonal and geographic differences in treatment-seeking and household cost of febrile illness among children in Malawi (2011) (56)
Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda. (2010) (55)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study (2021) (55)
Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea. (1996) (54)
Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. (1994) (54)
High Mortality amongst Adolescents and Adults with Bacterial Meningitis in Sub-Saharan Africa: An Analysis of 715 Cases from Malawi (2013) (54)
Travel-related infection in European travelers, EuroTravNet 2011. (2014) (54)
Infectious diseases acquired by international travellers visiting the USA. (2018) (53)
The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni). (1995) (52)
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. (2019) (52)
Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi* (2012) (51)
Adherence to Antiretroviral Therapy in Patients Receiving Free Treatment From a Government Hospital in Blantyre, Malawi (2007) (51)
Treatment of cryptococcal meningitis in resource limited settings (2009) (50)
Managing Advanced HIV Disease in a Public Health Approach (2018) (50)
Neuromuscular effects of papuan taipan snake venom (1995) (50)
Most Cases of Cryptococcal Meningitis in HIV-Uninfected Patients in Vietnam Are Due to a Distinct Amplified Fragment Length Polymorphism-Defined Cluster of Cryptococcus neoformans var. grubii VN1 (2010) (49)
Estimating the True Accuracy of Diagnostic Tests for Dengue Infection Using Bayesian Latent Class Models (2013) (49)
Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings (2017) (49)
The practice of ‘doing’ evaluation: lessons learned from nine complex intervention trials in action (2014) (46)
Epstein-Barr Virus Coinfection in Cerebrospinal Fluid Is Associated With Increased Mortality in Malawian Adults With Bacterial Meningitis (2011) (45)
Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni) (1995) (45)
Preventing malaria in travellers (2008) (45)
The Impact of Introducing Malaria Rapid Diagnostic Tests on Fever Case Management: A Synthesis of Ten Studies from the ACT Consortium (2017) (44)
The socio-economic burden of snakebite in Sri Lanka (2017) (44)
Healthcare‐seeking behaviour and use of traditional healers after snakebite in Hlabisa sub‐district, KwaZulu Natal (2007) (43)
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis (2022) (42)
A model for venom-induced consumptive coagulopathy in snake bite. (2008) (42)
Determinants and Consequences of Failure of Linkage to Antiretroviral Therapy at Primary Care Level in Blantyre, Malawi: A Prospective Cohort Study (2012) (41)
Cryptococcus neoformans in Papua New Guinea: a common pathogen but an elusive source. (1997) (39)
A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis (2016) (39)
Rolling Malaria Indicator Surveys (rMIS): a potential district-level malaria monitoring and evaluation (M&E) tool for program managers. (2012) (39)
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population (2017) (39)
Electrocardiographic abnormalities in patients bitten by taipans (Oxyuranus scutellatus canni) and other elapid snakes in Papua New Guinea. (1997) (38)
Rabies postexposure prophylaxis in a UK travel clinic: ten years' experience. (2011) (38)
Geographic Information System mapping of snakebite incidence in northern Ghana and Nigeria using environmental indicators: a preliminary study. (2003) (36)
Snake antivenom for snake venom induced consumption coagulopathy. (2015) (34)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (2018) (34)
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations (2014) (34)
A Randomized Controlled Trial of a Brief Intervention for Delayed Psychological Effects in Snakebite Victims (2015) (33)
AIDS-related mycoses: the way forward. (2014) (33)
Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi (2012) (33)
Trends in Adult Medical Admissions in a Rural South African Hospital Between 1991 and 2002 (2005) (33)
Health seeking behavior after fever onset in a malaria-endemic area of Malawi. (2009) (33)
Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans (2008) (33)
Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment (2010) (32)
Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme (2011) (32)
Development and Validation of a Global Positioning System–based “Map Book” System for Categorizing Cluster Residency Status of Community Members Living in High-Density Urban Slums in Blantyre, Malawi (2013) (32)
Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans (2019) (31)
The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims (2019) (31)
The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria (2013) (29)
A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming (2017) (29)
The emerging syndrome of envenoming by the New Guinea small-eyed snake Micropechis ikaheka. (1996) (28)
Neuroauditory Toxicity of Artemisinin Combination Therapies—Have Safety Concerns Been Addressed? (2014) (28)
Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. (1996) (27)
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine (2019) (27)
Electrophysiological findings in patients envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni). (1995) (27)
Recognising and Treatment Seeking for Acute Bacterial Meningitis in Adults and Children in Resource-Poor Settings: A Qualitative Study (2013) (27)
Evaluation of Plasmodium vivax malaria recurrence in Brazil (2019) (26)
Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans (2009) (26)
Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence (2016) (26)
Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi (2013) (26)
Neurotoxicity and haemostatic disturbances in patients envenomed by the Papuan black snake (Pseudechis papuanus). (1994) (25)
Promoting vulnerability or resilience to HIV? A qualitative study on polygamy in Maiduguri, Nigeria (2010) (25)
Health seeking behavior following snakebites in Sri Lanka: Results of an island wide community based survey (2017) (25)
Malaria: an update on treatment of adults in non-endemic countries (2006) (24)
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease (2018) (24)
Manson's Tropical Diseases Twenty-Third Edition (2013) (24)
Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE): protocol for a multisite prospective observational study of the causes of fever in Africa and Asia (2020) (23)
Sustained Reduction in Third-generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi (2020) (23)
Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these? (2010) (23)
An epidemiological study of snake bite envenomation in Papua New Guinea. (1992) (23)
A qualitative exploration of the human resource policy implications of voluntary counselling and testing scale-up in Kenya: applying a model for policy analysis (2011) (23)
Evaluating temporal patterns of snakebite in Sri Lanka: the potential for higher snakebite burdens with climate change (2018) (22)
The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy (2017) (21)
Failure of 3,4-diaminopyridine and edrophonium to produce significant clinical benefit in neurotoxicity following the bite of Papuan taipan (Oxyuranus scutellatus canni). (1995) (21)
Respiratory Virus–Associated Severe Acute Respiratory Illness and Viral Clustering in Malawian Children in a Setting With a High Prevalence of HIV Infection, Malaria, and Malnutrition (2016) (21)
CryptoDex: A randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial (2014) (21)
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data (2020) (21)
Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis (2018) (21)
Cost-Effectiveness of Community-based Human Immunodeficiency Virus Self-Testing in Blantyre, Malawi (2017) (21)
Compliance with long-term malaria prophylaxis in British expatriates. (2014) (21)
The African challenge (2002) (21)
Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis (2014) (20)
Identifying the biting species in snakebite by clinical features: an epidemiological tool for community surveys. (2006) (20)
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis. (2019) (20)
Fracture management in HIV positive individuals: a systematic review (2016) (20)
Randomized comparison of intramuscular artemether and intravenous quinine in adult, Melanesian patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea. (1998) (19)
Integrating human behavior and snake ecology with agent-based models to predict snakebite in high risk landscapes. (2021) (18)
Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi (2018) (18)
Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens (2015) (18)
Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites (2015) (18)
Changing epidemiology of HIV-associated cryptococcosis in sub-Saharan Africa. (2016) (17)
Snakebite: the true disease burden has yet to be determined. (2013) (17)
Investigation and treatment of imported malaria in non-endemic countries (2013) (17)
Southern Africa consortium for research excellence (SACORE): successes and challenges. (2014) (16)
Understanding Interpretations of and Responses to Childhood Fever in the Chikhwawa District of Malawi (2015) (16)
Successful primary prevention of cryptococcal disease using fluconazole prophylaxis in HIV-infected Ugandan adults (CRYPTOPRO) (2009) (16)
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data (2020) (16)
HIV/AIDS: a new South Africa takes responsibility. (2009) (16)
Increasing understanding of the relationship between geographic access and gendered decision-making power for treatment-seeking for febrile children in the Chikwawa district of Malawi (2016) (15)
Neurophysiological findings in patients 1 year after snake bite induced neurotoxicity in Sri Lanka. (2010) (15)
Venom detection kits in the management of snakebite in Central province, Papua New Guinea. (1995) (15)
Louse Infestation in Manson's Tropical Diseases (23rd Ed.) (2014) (15)
Designing Adverse Event Forms for Real-World Reporting: Participatory Research in Uganda (2012) (15)
Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study (2015) (15)
The 20-minute whole blood clotting test (20WBCT) for snakebite coagulopathy—A systematic review and meta-analysis of diagnostic test accuracy (2021) (14)
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial (2022) (14)
Cryptococcal meningoencephalitis: time for action. (2021) (14)
NEUROLOGICAL SYNDROMES AND THE TRAVELLER: AN APPROACH TO DIFFERENTIAL DIAGNOSIS (2004) (14)
Orthopaedic research in low-income countries: A bibliometric analysis of the current literature (2019) (14)
A piscatorial epistle. (1992) (13)
Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial (2019) (13)
Liver Function Test Abnormalities in Experimental and Clinical Plasmodium vivax Infection (2020) (13)
Exploring the complexity of microfinance and HIV in fishing communities on the shores of Lake Malawi (2015) (13)
Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS) (2016) (13)
Epidemiology and outcome of snake bite cases evaluated at a Tertiary Care Hospital in Oman. (2009) (13)
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi (2019) (12)
Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial (2018) (12)
Pharmacodynamics of Flubendazole for Cryptococcal Meningoencephalitis: Repurposing and Reformulation of an Anti-Parasitic Agent for a Neglected Fungal Disease (2018) (12)
Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis (2014) (12)
Chronic health effects and cost of snakebite (2021) (12)
Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi (2013) (12)
Will ART rollout in Africa drive an epidemic of drug resistant HIV? (2006) (12)
Arboviral and other illnesses in travellers returning from Brazil, June 2013 to May 2016: implications for the 2016 Olympic and Paralympic Games. (2016) (12)
Primary care influenza‐like illness surveillance in Ho Chi Minh City, Vietnam 2013‐2015 (2018) (12)
Drug induced chest pain—rare but important (2000) (12)
Management of venomous bites and stings in British Military Personnel deployed in Iraq, Afghanistan and Cyprus. (2008) (11)
Artesunate versus quinine for treating severe malaria. (2007) (11)
The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study (2017) (11)
Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception? (2013) (11)
Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis (2021) (11)
Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial (2019) (10)
Safety and effectiveness of apheresis in the treatment of infectious diseases: a systematic review. (2019) (10)
Use of nail and oral pigmentation to determine ART eligibility among HIV‐infected Ugandan adults (2010) (10)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter (2021) (10)
Epidemiology of Severe Acute Respiratory Illness and Risk Factors for Influenza Infection and Clinical Severity among Adults in Malawi, 2011–2013 (2018) (10)
Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa (2017) (9)
An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2 (2021) (9)
Pyomyositis in the upper Negro river basin, Brazilian Amazonia. (2012) (9)
Adjusting for spatial variation when assessing individual-level risk: A case-study in the epidemiology of snake-bite in Sri Lanka (2019) (9)
Challenges in HIV and visceral leishmania co-infection: future research directions. (2010) (9)
Initiation of antiretroviral therapy in HIV‐infected tuberculosis patients in rural Kenya: an observational study (2013) (8)
Analysis of referral letters to assess the management of poisonous snake bite in rural Papua New Guinea. (1994) (8)
in Blantyre , Malawi (2009) (8)
Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review (2021) (8)
Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report (2018) (8)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study (2021) (8)
Severe envenomation by the taipan (Oxyuranus scutellatus) (1997) (8)
Surveillance in easy to access population subgroups as a tool for evaluating malaria control progress: A systematic review (2017) (8)
Moderate-to-severe Vipera berus envenoming requiring ViperaTAb antivenom therapy in the UK (2021) (7)
The diagnosis of malaria: traditional and contemporary approaches. (1992) (7)
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis (2021) (7)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study (2019) (7)
Unstructured treatment interruption: an important risk factor for arterial stiffness in adult Malawian patients with antiretroviral treatment (2016) (6)
Multiple-dose activated charcoal in yellow oleander poisoning (2008) (6)
Prevention of acute adverse reactions to snake antivenom after snakebite: multi-centre, randomized, controlled clinical trial (2009) (6)
Intravenous antibiotic treatment at home can provide higher quality care (1997) (6)
Examining Intervention Design: Lessons from the Development of Eight Related Malaria Health Care Intervention Studies (2016) (6)
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial (2022) (6)
One year mortality outcomes from the ACTA trial of cryptococcal meningitis treatment in Malawi. (2019) (6)
Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis (2021) (6)
HOST study – HIV in orthopaedic skeletal trauma study : protocol for a multicentre case-cohort study (2018) (6)
Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study) (2018) (5)
Clinical diagnosis in paediatric patients at urban primary health care facilities in southern Malawi: a longitudinal observational study (2020) (5)
Measuring sexual behaviour in Malawi: a triangulation of three data collection instruments (2018) (5)
Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis (2015) (5)
Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi (2020) (5)
A randomized controlled trial for the treatment of HIV-associated cryptococcal meningitis in Africa: oral fluconazole plus flucytosine or one week amphotericin-based therapy versus two weeks amphotericin-based therapy. The ACTA Trial (2017) (5)
Rotational thromboelastometry alongside conventional coagulation testing in patients with Crimean–Congo haemorrhagic fever: an observational cohort study (2019) (5)
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults) (2022) (5)
Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial (2017) (5)
Fracture Healing in Patients With HIV in South Africa: A Prospective Cohort Study (2021) (5)
Artesunate versus quinine for treating severe malaria (Review) (2011) (5)
Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis (2018) (4)
Bites by exotic snakes reported to the UK National Poisons Information Service 2009–2020 (2022) (4)
CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Streptococcus pneumoniae Meningitis (2020) (4)
Antivenom use in Australia (1993) (4)
Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria (2021) (4)
Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy (2018) (4)
Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults (2018) (4)
Integrating snake distribution, abundance and expert‐derived behavioural traits predicts snakebite risk (2021) (3)
Venomous bites and stings (2001) (3)
A new look at an old drug: artemesinin and qinghaosu. (1992) (3)
Hydroquinone as a contact allergen : An overview (1997) (3)
A mechanistic model of snakebite as a zoonosis: Envenoming incidence is driven by snake ecology, socioeconomics and its impacts on snakes (2022) (3)
Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi (2014) (3)
Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection (2020) (3)
Unplanned ART treatment interruptions in Southern Africa: a literature review (2009) (3)
A Novel Community Health Worker Tool Outperforms WHO Clinical Staging for Assessment of Antiretroviral Therapy Eligibility in a Resource-Limited Setting (2014) (3)
Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study (2022) (3)
What the snake leaves in its wake: Functional limitations and disabilities among snakebite victims in Ghanaian communities (2022) (3)
Antivenom for snake venom-induced neuromuscular paralysis (2017) (3)
Economic costs and health-related quality of life outcomes of HIV treatment following self- and facility-based HIV testing in a cluster randomised trial. (2017) (2)
Chloroquine overdose in Papua New Guinea. (1993) (2)
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (2019) (2)
Case report forms (CRFs) used for the publication: Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection. (2020) (2)
Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in Southern Papua New Guinea (1996) (2)
Preface to the Twenty-Third Edition (2014) (2)
Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study). (2018) (2)
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
Management of vivax malaria with primaquine. (2007) (2)
Evaluating spatiotemporal dynamics of snakebite in Sri Lanka: Monthly incidence mapping from a national representative survey sample (2021) (2)
Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection. (2020) (2)
THE ACT CONSORTIUM AND THE GLOBAL HEALTH NETWORK: COLLABORATING TO PROVIDE AN ONLINE, OPEN-ACCESS, COMPREHENSIVE PHARMACOVIGILANCE RESOURCE FOR THOSE WORKING IN TROPICAL INFECTIOUS DISEASES AND GLOBAL HEALTH (2017) (2)
No room for complacency on drug resistance in Africa (2006) (2)
Safety and feasibility of apheresis to harvest and concentrate parasites from subjects with induced blood stage Plasmodium vivax infection (2020) (2)
Sex, power, marginalisation and HIV amongst young fishermen in Malawi: Exploring intersecting inequalities. (2020) (2)
Uniting behind a common goal: Collaboration between traditional healers and allopathic health care workers to improve rural snakebite care (2022) (1)
Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi (2014) (1)
Disorders of neuromuscular transmission due to natural environmental toxins (1993) (1)
Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'. (2007) (1)
Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study). (2018) (1)
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis (2023) (1)
Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis (2021) (1)
Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing (2022) (1)
The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria (2013) (1)
The symptom prevalence and burden in HIV-1-infected adults in rural Uganda (2009) (1)
A global core outcome measurement set for snakebite clinical trials. (2023) (1)
Myocardial effects of envenoming by elapids in Papua New Guinea (1996) (1)
Cerebrospinal fluid transcriptional analyses reveals upregulation of IL-17, Type 1 interferon transcriptional pathways and neutrophil persistence genes associated with increased mortality from pneumococcal meningitis in adults (2018) (1)
Cholera vaccines – Authors' reply (2007) (1)
Malaria (2019) (1)
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis (2022) (1)
Schistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails (2014) (1)
The epidemiological, clinical and laboratory features of snakebite in the central province and national capital district of Papua New Guinea. (1994) (1)
Letters to the Editors (2010) (1)
Treatment of yellow oleander poisoning with multiple dose activated charcoal: a randomized controlled trial (2003) (1)
A tale of three pandemics: Shining a light on a hidden problem (2021) (1)
Advances in the treatment of malaria. (2013) (1)
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023) (1)
Economic costs of accessing tuberculosis (TB) diagnostic services in Malawi: an analysis of patient costs from a randomised controlled trial of computer-aided chest x-ray interpretation (2021) (1)
Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans (2019) (1)
Genomics of Cryptococcus neoformans (2018) (1)
Climate change maladaptation for health: Agricultural practice against shifting seasonal rainfall affects snakebite risk for farmers in the tropics (2023) (0)
Envenoming Snakebite Risk Map for Sri Lanka (2016) (0)
Correction: The 20-minute whole blood clotting test (20WBCT) for snakebite coagulopathy—A systematic review and meta-analysis of diagnostic test accuracy (2023) (0)
Immune Escape in Hiv Infection (1995) (0)
Qualitative analysis of factors affecting the selection of health seeking behaviour and patient preferences of anti-malarial drugs in Zomba, Malawi [MIM-IB-177045] (2005) (0)
Malaria in the Returned Traveler (2020) (0)
A fever study at the Colombo North Teaching Hospital (CNTH) (2007) (0)
Anaemia in a rural cohort of HIV-infected Ugandans receiving either AZT- or non AZT-containing antiretroviral regimens (2009) (0)
South American trypanosomiasis (Chagas' disease) (2014) (0)
Chapter 105 – African trypanosomiasis (2010) (0)
Prevalence of disability among the study groups (SDI). (2015) (0)
Low-dose adrenaline, promethazine and hydrocortisone, (alone and in combination) in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double blind, placebo-controlled trial (2011) (0)
Mycobacterium Tuberculosis Blood Stream Infection Prevalence, Diagnosis, and Mortality Hazard in HIV-Positive Adults: A Systematic Review and Meta-Analysis of Individual Patient Data (2019) (0)
Co-prevalent infections in adults with HIV-associated cryptococcal meningitis are associated with an increased risk of death: a nested analysis of the Advancing Cryptococcal meningitis Treatment for Africa (ACTA) cohort (2021) (0)
Ischemic Heart Disease after Breast Cancer Radiotherapy (2014) (0)
Travel medicine (2003) (0)
Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial (2019) (0)
Malaria: clinical features and recommended management (2006) (0)
The emerging syndrome of envenoming by the New Guinean small-eyed snake (Micropechis ikaheka Lesson) (1995) (0)
Population pharmacokinetics (PK) of nevirapine (NVP) in HIV-infected adults (2009) (0)
Livestock herding and Fulani ethnicity are a combined risk factor for development of early adverse reactions to antivenom treatment: Findings from a cross-sectional study in Nigeria (2021) (0)
Beliefs and knowledge regarding snakebite in rural Sri Lanka: a qualitative survey (2003) (0)
THE IMPACT PROJECT: IMPROVING THE IMPACT OF EXISTING MALARIA PRODUCTS – ACTS (2017) (0)
845Prediction of Outcome from Adult Bacterial Meningitis in a High HIV Seroprevelence, Resource-Poor Setting Using a New Severity Scoring Tool, the Malawi Adult Meningitis Score (MAMS) (2014) (0)
Is human immunodeficiency virus a risk factor for the development of nonunion?—a case–control study (2023) (0)
Antimalarial Pharmacology and Therapeutics of Atovaquone 1 2 (2017) (0)
Malaria and Travellers (2013) (0)
Combination Antifungal Therapy for Cryptococcal Meningitis - Authors Reply (2013) (0)
Prevalence of post-traumatic stress disorder among the study groups. (2015) (0)
Other fungal infections (2014) (0)
OBSERVED QTC PROLONGATION AND PHARMACOKINETIC PROFILE OF A PROGRAMMATIC REGIMEN WITH AN INCREASED DOSE OF DIHYDROARTEMISININ-PIPERAQUINE IN YOUNG CHILDREN 5-24 KG IN MALAWI (2015) (0)
22. Venomous Bites and Stings (2013) (0)
The effect of compliance upon clinical effectiveness of chlorproguanil-dapsone (CD) and artemether-lumefantrine (AL) when compared to sulfadoxine-pyrimethamine (SP) for the treatment of uncomplicated falciparum malaria in Malawi - A randomised controlled trial (2007) (0)
Author response: An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis (2021) (0)
Adult bacterial meningitis in Malawi: A randomised controlled trail of steroid adjuvant therapy and a comparison of intravenous and intramuscular ceftriaxone (2008) (0)
The Ceylon Medical Journal Editors Emeritus the Influenza Viruses (0)
Both the inflammatory response and clinical outcome differ markedly between adults with pneumococcal and meningococcal meningitis in a high HIV-1 prevalent setting in sub-Saharan Africa (2019) (0)
Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults (2018) (0)
Practice point 55 – History of an animal bite in a returned traveler from Burma (2010) (0)
Caring for women in their post reproductive life: current recommendations on hormone replacement therapy (2015) (0)
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis (2022) (0)
List of Contributors (2019) (0)
Malaria in returned traveler (2012) (0)
Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial (2019) (0)
Antivenom for snake venom-induced neuromuscular paralysis (Protocol) (2017) (0)
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis. [version 1; peer review: 2 approved, 1 approved with reservations] (2020) (0)
Evaluation of Plasmodium vivax malaria recurrence in Brazil (2019) (0)
An Action Plan for Change Preventing and Treating Snakebite in Resource-Poor Settings (0)
Safety and feasibility of apheresis to harvest and concentrate parasites from subjects with induced blood stage Plasmodium vivax infection (2021) (0)
Bites and stings (2014) (0)
Monocyte deactivation is associated with mortality in HIV-associated cryptococcal meningitis (2015) (0)
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
837Early Goal Directed Therapy for Acute Bacterial Meningitis in Malawian Adults (2014) (0)
Redefining snakebite envenoming as a zoonosis: disease incidence is driven by snake ecology, socioeconomics and anthropogenic impacts (2021) (0)
ART Eligibility Guidelines and Development of Novel ART Eligibility Screening Tool (2015) (0)
Where do the Artemisinins Fit in the Treatment Armamentarium (2009) (0)
Malaria after international travel: a GeoSentinel analysis, 2003–2016 (2017) (0)
Development and assessment of a psychological intervention for snakebite victims (2014) (0)
Increasing understanding of the relationship between geographic access and gendered decision-making power for treatment-seeking for febrile children in the Chikwawa district of Malawi (2016) (0)
Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based (2019) (0)
Community incidence of snakebite and envenoming in Sri Lanka; results of a national survey (2014) (0)
COVID-19: Challenges and solutions: Updates on treatment, vaccines and prophylaxis (2020) (0)
The characterisation of the loss of B cell memory to pneumococcal protein antigens in Malawian children during HIV infection (2009) (0)
Guardians and research staff experiences and views about the consent process in hospital-based paediatric research studies in urban Malawi: A qualitative study (2022) (0)
Severity of depression among the study groups (BDI). (2015) (0)
Cholera vaccines - Reply (2007) (0)
Genome-Wide Association Study of Nevirapine Hypersensitivity in a sub-Saharan 1 African HIV-infected Population 2 3 (2016) (0)
Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial (2018) (0)
Methods : An open-label phase III randomised controlled non-inferiority trial conducted in five countries in sub-Saharan Africa (2019) (0)
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19 (2022) (0)
The effect of anti-retroviral therapy on fracture healing (2022) (0)
Snakebite in rural KwaZulu Natal: incidence, healthcare-seeking behaviour and use of traditional healers (2007) (0)
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine (2019) (0)
I76. The Challenges of Snakebite (2014) (0)
Immune escape through T cell antagonism (1996) (0)
Delayed psychological morbidity in victims of snakebite envenoming (2010) (0)
Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study (2015) (0)
List of Contributors (2020) (0)
Results of the Hopkin’s psychiatric symptoms checklist among study groups. (2015) (0)
Development of a Snakebite risk map for Sri Lanka (2016) (0)
Paediatric snakebite in Kilifi County, Kenya: A 19-year observational study (2022) (0)
Ophthalmic features of HIV associated cryptococcal meningitis in Malawian Adults: an observational study (2019) (0)
The Global Challenge of Snakebite: where are we in 2016? (2016) (0)
Health seeking behavior of snakebite victims in Sri Lanka: findings from an island-wide community-based study (2014) (0)
Charles Darwin University Liver function test abnormalities in experimental and clinical plasmodium vivax infection Odedra, (2020) (0)
Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi: A Ran- (2018) (0)
Corrigendum to “UK malaria treatment guidelines” [Journal of Infection 54 (2007) 111–121] (2009) (0)

This paper list is powered by the following services:

Other Resources About David Lalloo

en.wikipedia.org

What Schools Are Affiliated With David Lalloo?

David Lalloo is affiliated with the following schools:

David Lalloo's Academic­Influence.com Rankings